{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:32:59Z","timestamp":1787020379501,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011471","name":"Shanghai Minhang Health And Family Planning Commission","doi-asserted-by":"publisher","award":["20184Y0189"],"award-info":[{"award-number":["20184Y0189"]}],"id":[{"id":"10.13039\/501100011471","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dermatomyositis (DM) is a systemic autoimmune inflammatory disorder that affects primarily skin, muscle and lung, frequently associated with interstitial lung disease (ILD). The objective of this study is to investigate the association between serum cytokines and clinical severity in patients with DM-ILD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serum samples of 30 healthy controls, 14 DM patients without ILD and 40 DM patients with ILD were collected. Serum S100A8\/A9 levels were analyzed by enzyme-linked immunosorbent assay (ELISA) and levels of interleukins were measured by cytometric beads array (CBA). Then we performed multivariate logistic regression analysis to determine factors independently associated with ILD development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Serum IL-4, IL-6 and S100A8\/A9 levels were significantly higher in DM patients with ILD than those in healthy controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0013, 0.0017 and\u2009&lt;\u20090.0001, respectively). Serum IL-10 level of patients was dramatically lower than that in controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0001). In DM patients, the levels were significantly higher in patients with A\/SIP than in those with CIP (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0046, 0.0339 and 0.0133) or without ILD (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0165, 0.0370 and\u2009&lt;\u20090.0001). IL-4 (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.1171,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0040), IL-6 (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.1174,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0040) and IL-10 (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u2212\u20090.1829,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0003) were significantly correlated with S100A8\/A9 in DM-ILD patients. S100A8\/A9 was significantly correlated with high-resolution computed tomography (HRCT) (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.1642,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0157) and lung function (DLCO%:\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u2212\u20090.2066,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0061, FVC%:\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u2212\u20090.2156,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0050). Moreover, logistic regression analysis revealed that S100A8\/A9 levels were independently associated with ILD development in DM patients (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Serum level of S100A8\/A9 may be a valuable predictor for assessing the clinical severity of DM-ILD patients. Serum IL-4, IL-6 and IL-10 levels were highly correlated with S100A8\/A9, so these cytokines may play a synergistic effect on the progression of DM-ILD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-020-01226-3","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T10:26:01Z","timestamp":1594981561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Serum levels of interleukins and S100A8\/A9 correlate with clinical severity in patients with dermatomyositis-associated interstitial lung disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Yueyan","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8437-1145","authenticated-orcid":false,"given":"Qing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"issue":"136","key":"1226_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1183\/16000617.00002015","volume":"24","author":"JC Lega","year":"2015","unstructured":"Lega JC, et al. Idiopathic inflammatory myopathies and the lung. Eur Respir Rev. 2015;24(136):216\u201338.","journal-title":"Eur Respir Rev"},{"issue":"2","key":"1226_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1055\/s-0034-1371528","volume":"35","author":"RW Hallowell","year":"2014","unstructured":"Hallowell RW, Ascherman DP, Danoff SK. Pulmonary manifestations of polymyositis\/dermatomyositis. Semin Respir Crit Care Med. 2014;35(2):239\u201348.","journal-title":"Semin Respir Crit Care Med"},{"key":"1226_CR3","doi-asserted-by":"crossref","unstructured":"Hanaoka M, et al. KL-6 is a long-term disease-activity biomarker for interstitial lung disease associated with polymyositis\/dermatomyositis, but is not a short-term disease-activity biomarker. Mod Rheumatol. 2018:1\u201320.","DOI":"10.1080\/14397595.2018.1553488"},{"key":"1226_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jns.2018.12.040","volume":"397","author":"L Li","year":"2019","unstructured":"Li L, et al. Myositis-specific autoantibodies in dermatomyositis\/polymyositis with interstitial lung disease. J Neurol Sci. 2019;397:123\u20138.","journal-title":"J Neurol Sci"},{"issue":"5","key":"1226_CR5","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.chest.2016.04.007","volume":"150","author":"J Morisset","year":"2016","unstructured":"Morisset J, et al. Management of Myositis-Related Interstitial Lung Disease. Chest. 2016;150(5):1118\u201328.","journal-title":"Chest"},{"issue":"2","key":"1226_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/ar2139","volume":"9","author":"C Grundtman","year":"2007","unstructured":"Grundtman C, Malmstrom V, Lundberg IE. Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies. Arthritis Res Ther. 2007;9(2):208.","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"1226_CR7","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.nmd.2014.06.432","volume":"24","author":"EM Moran","year":"2014","unstructured":"Moran EM, Mastaglia FL. The role of interleukin-17 in immune-mediated inflammatory myopathies and possible therapeutic implications. Neuromuscul Disord. 2014;24(11):943\u201352.","journal-title":"Neuromuscul Disord"},{"key":"1226_CR8","first-page":"77","volume":"5","author":"Y Shimojima","year":"2012","unstructured":"Shimojima Y, et al. Phenotypes of peripheral blood lymphocytes and cytokine expression in Polymyositis and Dermatomyositis before treatment and after clinical remission. Clin Med Insights Arthritis Musculoskelet Disord. 2012;5:77\u201387.","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"issue":"4","key":"1226_CR9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.21873\/invivo.11108","volume":"31","author":"M Giris","year":"2017","unstructured":"Giris M, et al. Elevated IL-4 and IFN-gamma levels in muscle tissue of patients with Dermatomyositis. Vivo. 2017;31(4):657\u201360.","journal-title":"Vivo"},{"issue":"1","key":"1226_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/cei.12311","volume":"177","author":"T Fujiyama","year":"2014","unstructured":"Fujiyama T, et al. Preferential infiltration of interleukin-4-producing CXCR4+ T cells in the lesional muscle but not skin of patients with dermatomyositis. Clin Exp Immunol. 2014;177(1):110\u201320.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"1226_CR11","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/rheumatology\/keq380","volume":"50","author":"Z Rasheed","year":"2011","unstructured":"Rasheed Z, Akhtar N, Haqqi TM. Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-kappaB in human osteoarthritis chondrocytes. Rheumatology (Oxford). 2011;50(5):838\u201351.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1226_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1590\/1516-4446-2015-1843","volume":"39","author":"SA Guloksuz","year":"2017","unstructured":"Guloksuz SA, et al. Elevated plasma concentrations of S100 calcium-binding protein B and tumor necrosis factor alpha in children with autism spectrum disorders. Braz J Psychiatry. 2017;39(3):195\u2013200.","journal-title":"Braz J Psychiatry"},{"issue":"4","key":"1226_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1471-4906(03)00062-0","volume":"24","author":"J Roth","year":"2003","unstructured":"Roth J, et al. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol. 2003;24(4):155\u20138.","journal-title":"Trends Immunol"},{"issue":"12","key":"1226_CR14","doi-asserted-by":"publisher","first-page":"7706","DOI":"10.1016\/S0021-9258(20)89506-4","volume":"266","author":"J Edgeworth","year":"1991","unstructured":"Edgeworth J, et al. Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J Biol Chem. 1991;266(12):7706\u201313.","journal-title":"J Biol Chem"},{"issue":"5","key":"1226_CR15","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.4049\/jimmunol.180.5.3366","volume":"180","author":"MA Raquil","year":"2008","unstructured":"Raquil MA, et al. Blockade of antimicrobial proteins S100A8 and S100A9 inhibits phagocyte migration to the alveoli in streptococcal pneumonia. J Immunol. 2008;180(5):3366\u201374.","journal-title":"J Immunol"},{"issue":"9","key":"1226_CR16","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/nm1638","volume":"13","author":"T Vogl","year":"2007","unstructured":"Vogl T, et al. Mrp8 and Mrp14 are endogenous activators of toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med. 2007;13(9):1042\u20139.","journal-title":"Nat Med"},{"issue":"11","key":"1226_CR17","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1164\/rccm.200810-1552OC","volume":"180","author":"MA van Zoelen","year":"2009","unstructured":"van Zoelen MA, et al. Expression and role of myeloid-related protein-14 in clinical and experimental sepsis. Am J Respir Crit Care Med. 2009;180(11):1098\u2013106.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1226_CR18","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1002\/jcb.27844","volume":"120","author":"X Liang","year":"2019","unstructured":"Liang X, et al. Platelet-neutrophil interaction aggravates vascular in fl ammation and promotes the progression of atherosclerosis by activating the TLR4\/NF-kappaB pathway. J Cell Biochem. 2019;120(4):5612\u20139.","journal-title":"J Cell Biochem"},{"issue":"5","key":"1226_CR19","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1186\/ar4311","volume":"15","author":"K Nistala","year":"2013","unstructured":"Nistala K, et al. Myeloid related protein induces muscle derived inflammatory mediators in juvenile dermatomyositis. Arthritis Res Ther. 2013;15(5):R131.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"1226_CR20","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.rmed.2013.03.015","volume":"107","author":"R Hesselstrand","year":"2013","unstructured":"Hesselstrand R, et al. Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis. Respir Med. 2013;107(7):1079\u201386.","journal-title":"Respir Med"},{"issue":"1","key":"1226_CR21","first-page":"63","volume":"48","author":"L Yunchun","year":"2018","unstructured":"Yunchun L, et al. Clinical significance of myeloid-related protein 8\/14 as a predictor for biological treatment and disease activity in rheumatoid arthritis. Ann Clin Lab Sci. 2018;48(1):63\u20138.","journal-title":"Ann Clin Lab Sci"},{"issue":"8","key":"1226_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403\u20137.","journal-title":"N Engl J Med"},{"issue":"7","key":"1226_CR23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344\u20137.","journal-title":"N Engl J Med"},{"issue":"2 Pt 1","key":"1226_CR24","first-page":"646","volume":"161","author":"American Thoracic Society","year":"2000","unstructured":"American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000;161(2 Pt 1):646\u201364.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1226_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/00005382-199623000-00002","volume":"11","author":"J Ikezoe","year":"1996","unstructured":"Ikezoe J, et al. High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J Thorac Imaging. 1996;11(4):250\u20139.","journal-title":"J Thorac Imaging"},{"issue":"5","key":"1226_CR26","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1172\/JCI70966","volume":"124","author":"Y Wang","year":"2014","unstructured":"Wang Y, et al. Platelet-derived S100 family member myeloid-related protein-14 regulates thrombosis. J Clin Invest. 2014;124(5):2160\u201371.","journal-title":"J Clin Invest"},{"issue":"2","key":"1226_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/0961203316655208","volume":"26","author":"H Tyden","year":"2017","unstructured":"Tyden H, et al. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus. Lupus. 2017;26(2):139\u201349.","journal-title":"Lupus"},{"issue":"4","key":"1226_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5415\/apallergy.2014.4.4.187","volume":"4","author":"TH Lee","year":"2014","unstructured":"Lee TH, Song HJ, Park CS. Role of inflammasome activation in development and exacerbation of asthma. Asia Pac Allergy. 2014;4(4):187\u201396.","journal-title":"Asia Pac Allergy"},{"issue":"1","key":"1226_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1365-2796.2010.02340.x","volume":"270","author":"K Andreasson","year":"2011","unstructured":"Andreasson K, et al. Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis. J Intern Med. 2011;270(1):50\u20137.","journal-title":"J Intern Med"},{"issue":"2","key":"1226_CR30","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1365-2249.2010.04181.x","volume":"161","author":"NM Korthagen","year":"2010","unstructured":"Korthagen NM, et al. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases. Clin Exp Immunol. 2010;161(2):342\u20137.","journal-title":"Clin Exp Immunol"},{"key":"1226_CR31","doi-asserted-by":"publisher","first-page":"717130","DOI":"10.1155\/2011\/717130","volume":"2011","author":"E Bargagli","year":"2011","unstructured":"Bargagli E, et al. Macrophage-derived biomarkers of idiopathic pulmonary fibrosis. Pulm Med. 2011;2011:717130.","journal-title":"Pulm Med"},{"issue":"4","key":"1226_CR32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.rmed.2011.12.010","volume":"106","author":"A Hara","year":"2012","unstructured":"Hara A, et al. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis. Respir Med. 2012;106(4):571\u201380.","journal-title":"Respir Med"},{"issue":"9","key":"1226_CR33","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.4049\/jimmunol.1202246","volume":"189","author":"SP Gadani","year":"2012","unstructured":"Gadani SP, et al. IL-4 in the brain: a cytokine to remember. J Immunol. 2012;189(9):4213\u20139.","journal-title":"J Immunol"},{"issue":"12","key":"1226_CR34","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1093\/rheumatology\/keu258","volume":"53","author":"T Gono","year":"2014","unstructured":"Gono T, et al. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease. Rheumatology (Oxford). 2014;53(12):2196\u2013203.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"1226_CR35","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/rheumatology\/keq196","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono T, et al. Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease. Rheumatology (Oxford). 2010;49(10):1878\u201381.","journal-title":"Rheumatology (Oxford)"},{"key":"1226_CR36","doi-asserted-by":"publisher","first-page":"815245","DOI":"10.1155\/2014\/815245","volume":"2014","author":"H Kawasumi","year":"2014","unstructured":"Kawasumi H, et al. IL-6, IL-8, and IL-10 are associated with hyperferritinemia in rapidly progressive interstitial lung disease with polymyositis\/dermatomyositis. Biomed Res Int. 2014;2014:815245.","journal-title":"Biomed Res Int"},{"issue":"12","key":"1226_CR37","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1002\/art.34659","volume":"64","author":"AM Reed","year":"2012","unstructured":"Reed AM, et al. Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course. Arthritis Rheum. 2012;64(12):4078\u201386.","journal-title":"Arthritis Rheum"},{"key":"1226_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","volume":"29","author":"W Ouyang","year":"2011","unstructured":"Ouyang W, et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011;29:71\u2013109.","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"1226_CR39","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41590-018-0083-5","volume":"19","author":"L Gabrysova","year":"2018","unstructured":"Gabrysova L, et al. C-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4(+) T cells. Nat Immunol. 2018;19(5):497\u2013507.","journal-title":"Nat Immunol"},{"key":"1226_CR40","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1038\/ncomms4551","volume":"5","author":"CC Lin","year":"2014","unstructured":"Lin CC, et al. Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation. Nat Commun. 2014;5:3551.","journal-title":"Nat Commun"},{"issue":"11","key":"1226_CR41","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1002\/art.30513","volume":"63","author":"I Marie","year":"2011","unstructured":"Marie I, et al. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum. 2011;63(11):3439\u201347.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1226_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0720-048X(03)00094-9","volume":"49","author":"O Bonnefoy","year":"2004","unstructured":"Bonnefoy O, et al. Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis. Eur J Radiol. 2004;49(3):235\u201344.","journal-title":"Eur J Radiol"},{"issue":"4","key":"1226_CR43","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","volume":"183","author":"B Ley","year":"2011","unstructured":"Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183(4):431\u201340.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01226-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-020-01226-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01226-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T06:09:00Z","timestamp":1650521340000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-020-01226-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1226"],"URL":"https:\/\/doi.org\/10.1186\/s12890-020-01226-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-15869\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]},"assertion":[{"value":"3 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board of RenJi Hospital (2016075). Since all data were anonymously used and this study does not contain protected health information, the ethics committee approved a waiver of the requirement for informed consent. Individual patients consent was not obtained since all data used in this study were acquired retrospectively from the laboratory information system without any additional sampling or laboratory analysis. Patients could choose to opt out at any time and have their data removed from the registry.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}